玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
24Q1 (20)750.00.00.290.026.090.24-14.294.350.29-71.8426.093.1210.6418.1823.048.4210.827.30-22.59-7.836.86-8.93.310.23-14.819.520.210.016.678.35-11.171.586.86-8.93.312.1713.0498.41
23Q4 (19)750.00.00.2926.0961.110.28211.1147.371.0339.1922.622.82-6.319.321.2514.259.429.43141.7941.87.5330.2842.880.27125.058.820.2123.5350.09.4029.1240.097.5330.2842.88-1.795.6475.12
23Q3 (18)750.00.00.23-14.810.00.09-60.87-57.140.7445.112.123.012.7314.0218.60-13.08-12.433.90-49.55-48.215.78-16.83-9.550.12-47.83-40.00.17-15.00.07.28-15.84-8.775.78-16.83-9.556.861.29-30.43
23Q2 (17)750.00.00.2717.390.00.230.0187.50.51121.7418.62.9310.9821.5821.402.9310.487.73-2.450.986.954.67-16.060.239.5291.670.211.110.08.655.23-19.386.954.67-16.066.6622.5910.53
23Q1 (16)750.00.00.2327.7843.750.2321.0553.330.23-72.6243.752.642.333.9420.797.05-1.77.9219.137.026.6426.038.620.2123.5340.00.1828.5750.08.2222.537.466.6426.038.620.033.025.77
22Q4 (15)750.00.00.18-21.74-47.060.19-9.5218.750.8427.2713.512.58-2.275.7419.42-8.57-2.416.65-11.69-15.55.27-17.53-48.590.17-15.0-10.530.14-17.65-44.06.71-15.91-48.425.27-17.53-48.593.63-18.2776.49
22Q3 (14)750.00.00.23-14.8191.670.21162.575.00.6653.4960.982.649.5415.2821.249.65-9.667.5347.0758.536.39-22.8362.180.266.6781.820.17-15.088.897.98-25.6361.876.39-22.8362.182.2126.9757.91
22Q2 (13)750.00.00.2768.75107.690.08-46.67-38.460.43168.7548.282.41-5.125.2419.37-8.42-9.875.12-11.42-1.928.2872.8694.370.12-20.00.00.266.67100.010.7379.43101.318.2872.8694.37-0.517.91-26.46
22Q1 (12)750.00.00.16-52.946.670.15-6.25-6.250.16-78.386.672.544.14.121.156.28-8.085.78-26.5613.564.79-53.271.480.15-21.0525.00.12-52.00.05.98-54.0413.264.79-53.271.485.3265.2013.54
21Q4 (11)750.015.380.34183.33240.00.1633.33128.570.7480.492.782.446.55-19.4719.90-15.3612.687.8765.68248.2310.25160.15385.780.1972.73171.430.25177.78316.6713.01163.89376.5610.25160.15385.783.2787.8212.82
21Q3 (10)750.00.00.12-7.69100.00.12-7.69140.00.4141.38-37.882.290.0-17.6323.519.436.774.75-9.097.923.94-7.51150.960.11-8.3357.140.09-10.0125.04.93-7.594.863.94-7.51150.96-3.08-10.51-13.22
21Q2 (9)750.010.290.13-13.33-56.670.13-18.7562.50.2993.33-55.382.29-6.15-18.2121.49-6.6125.385.222.5512.264.26-9.75-41.640.120.0-7.690.1-16.67-50.05.330.95-45.394.26-9.75-41.64-12.8118.3454.91
21Q1 (8)7515.3866.670.1550.0-58.330.16128.57-33.330.15-79.17-58.332.44-19.47-37.623.0130.2932.75.09125.22-8.784.72123.714.840.1271.43-45.450.12100.0-25.05.2893.412.724.72123.714.84-5.2458.3484.28
20Q4 (7)65-13.3344.440.1066.67-67.740.0740.0-56.250.729.09-47.063.038.995.2117.662.73-12.312.26-5.83-58.232.1134.39-55.490.070.0-56.250.0650.0-57.142.737.91-56.182.1134.39-55.494.14-6.661.25
20Q3 (6)7510.2966.670.06-80.0-75.00.05-37.5-68.750.661.54-37.142.78-0.71-1.0717.190.2935.042.40-48.39-52.11.57-78.49-58.790.07-46.15-50.00.04-80.0-63.642.53-74.08-43.531.57-78.49-58.79-14.55-48.34-52.09
20Q2 (5)6851.1151.110.30-16.67-33.330.08-66.67-46.670.6580.56-19.752.8-28.3915.717.14-1.15-16.554.65-16.67-23.147.3077.62-12.890.13-40.91-13.330.225.00.09.7689.88-2.117.3077.62-12.89--0.00
20Q1 (4)450.00.00.3616.130.00.2450.00.00.36-73.530.03.9135.760.017.34-13.90.05.583.140.04.11-13.290.00.2237.50.00.1614.290.05.14-17.50.04.11-13.290.0--0.00
19Q4 (3)450.00.00.3129.170.00.160.00.01.3629.520.02.882.490.020.1458.210.05.417.980.04.7424.410.00.1614.290.00.1427.270.06.2339.060.04.7424.410.0--0.00
19Q3 (2)450.00.00.24-46.670.00.166.670.01.0529.630.02.8116.120.012.73-38.020.05.01-17.190.03.81-54.530.00.14-6.670.00.11-45.00.04.48-55.070.03.81-54.530.0--0.00
19Q2 (1)450.00.00.450.00.00.150.00.00.810.00.02.420.00.020.540.00.06.050.00.08.380.00.00.150.00.00.20.00.09.970.00.08.380.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/51.1121.0714.215.1514.33.02N/A-
2024/40.92-6.782.834.0414.322.71N/A-
2024/30.9922.718.133.1218.233.120.42-
2024/20.8-39.29-10.932.1323.583.170.42-
2024/11.3327.4761.611.3361.613.270.4適逢農曆春節連假,客戶備貨所致。
2023/121.0415.426.5511.3911.932.820.49-
2023/110.92.74.3610.3512.52.830.49-
2023/100.88-16.8817.859.4513.343.060.45-
2023/91.06-6.0625.798.5812.93.00.34-
2023/81.1237.748.797.5211.33.010.34-
2023/70.82-23.926.276.411.752.860.36-
2023/61.079.8632.785.5812.62.940.33-
2023/50.989.012.414.518.672.780.34-
2023/40.9-1.9821.643.537.682.710.35-
2023/30.911.071.592.643.642.640.48-
2023/20.910.1529.081.724.772.70.47-
2023/10.82-15.94-13.230.82-13.232.660.48-
2022/120.9813.041.2710.187.652.580.43-
2022/110.8615.977.119.28.372.450.45-
2022/100.74-11.2711.08.348.52.620.42-
2022/90.84-18.757.977.68.262.640.35-
2022/81.0334.5518.826.768.32.610.35-
2022/70.77-4.9519.145.726.62.440.38-
2022/60.81-6.976.174.964.892.410.36-
2022/50.8717.952.544.154.642.50.34-
2022/40.74-18.134.833.285.212.340.37-
2022/30.928.4216.082.545.322.540.35-
2022/20.7-25.95-5.171.650.242.610.34-
2022/10.95-1.894.680.954.682.720.32-
2021/120.9619.5635.859.46-24.432.440.36-
2021/110.8120.19-5.768.49-28.052.250.39-
2021/100.67-13.7-54.237.69-29.792.320.38因疫情影響,本期營收下滑。
2021/90.78-10.59-3.467.02-26.012.290.4-
2021/80.8734.92-18.196.24-28.112.270.4-
2021/70.64-15.3-29.375.37-29.492.250.41-
2021/60.76-10.15-5.344.73-29.512.310.26-
2021/50.8520.58-12.463.96-32.82.320.26-
2021/40.7-9.35-31.613.12-36.782.220.28-
2021/30.774.9-35.922.42-38.142.420.28-
2021/20.74-18.25-53.781.64-39.142.350.28本月因農曆春節工作天數少,致營收下降。
2021/10.927.32-17.870.9-17.872.470.27-
2020/120.71-17.06-26.3312.5112.523.030.26-
2020/110.86-41.63-22.5111.816.23.130.26-
2020/101.4782.0481.1410.9520.923.330.24因市面上流感疫苗缺貨,醫生建議民眾轉施打本公司經銷之肺炎鏈球菌疫苗所致。
2020/90.81-24.2432.89.4815.012.780.21-
2020/81.0616.49-28.128.6813.62.780.21-
2020/70.9113.525.447.6223.612.680.22-
2020/60.8-16.9120.036.723.372.80.17-
2020/50.97-5.79-13.975.923.843.20.15-
2020/41.03-15.0766.284.9335.523.830.13本月營收較去年同期增加係因民眾保健意識提高,施打肺炎鏈球菌疫苗數量增加所致
2020/31.21-24.330.023.9129.233.910.15-
2020/21.645.2679.912.748.693.660.16本月營收較去年同期增加係因疫情期間醫療院所預先備藥所致
2020/11.114.2118.751.118.753.170.18-
2019/120.96-12.7727.7411.12-14.562.880.18-
2019/111.136.45-32.7910.16-17.162.520.21-
2019/100.8133.46-22.339.05-14.742.890.18-
2019/90.61-58.99-27.328.25-13.922.810.21-
2019/81.48103.310.577.64-12.642.870.21-
2019/70.738.6-32.616.16-16.830.0N/A-
2019/60.67-40.44-13.25.43-14.140.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)750.01.0221.430.8431.2511.411.9820.480.847.1813.976.719.110.8228.120.9520.250.7722.22
2022 (9)750.00.8413.510.6416.3610.187.6120.31-7.516.309.386.155.130.6418.520.7916.180.6314.55
2021 (8)7515.380.742.780.5525.09.46-24.3821.9626.645.7649.225.8554.760.5412.50.687.940.5517.02
2020 (7)6544.440.72-47.060.44-36.2312.5112.517.34-3.723.86-34.473.78-30.640.48-27.270.63-16.00.47-22.95
2019 (6)450.01.3621.430.692.9911.12-14.5918.015.885.8964.995.4541.190.6643.480.7563.040.6122.0
2018 (5)450.01.12833.330.67346.6713.028.1417.0126.943.571452.173.86797.670.461433.330.4600.5900.0
2017 (4)450.00.12-80.00.15-72.7312.04-7.7413.40-16.820.23-93.750.43-79.130.03-93.75-0.0300.05-81.48
2016 (3)450.00.607.140.55-3.5113.05-2.6816.11-1.13.68-23.332.0610.160.48-25.00.34-26.090.278.0
2015 (2)450.00.56-29.110.57-14.9313.41-1.416.29-0.494.8013.211.87-27.520.6410.340.469.520.25-28.57
2014 (1)4528.570.79-51.530.67-33.6613.6-5.9516.3704.2402.5800.58-32.560.42-37.310.35-38.6

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。